Assesing the comparative ability of Human epidermal growth factor and the Insulin-like growth factor-1 coated membranes in the treatment of receeding gums.
Phase 4
- Registration Number
- CTRI/2024/04/066294
- Lead Sponsor
- Sibar Institute of Dental Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age group 18-45 years.
2.Subjects who are apparently healthy.
3.Presence of Miller’s Class I gingival recession.
4.Width of keratinized gingiva (KGW) =2 mm.
5.Presence of identifiable Cemento-Enamel Junction (CEJ).
6.Subjects who are willing to give informed consent.
Exclusion Criteria
1.Subjects under medication.
2.Wasting diseases.
3.Presence of caries, furcations involvement in isolated gingival recessions.
4.Pregnant or lactating females.
5.Any form of Tobacco users.
6.Subjects with Tooth mobility.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Keratinized Gingival Width (KGW) <br/ ><br>Wound Healing Index (WHI) <br/ ><br>Percentage of Root Coverage (PRC)Timepoint: baseline,2 weeks, 3 months,6 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Probing Depth (PD) <br/ ><br>Clinical Attachment Level (CAL) <br/ ><br>Recession Depth (RD) <br/ ><br>Recession Width (RW) <br/ ><br>Gingival Thickness (GT) <br/ ><br> <br/ ><br>Timepoint: baseline, 3 months,6 months